Search results
Elite Pharmaceuticals Receives FDA Approval for Generic Methotrexate
Digital Journal· 4 days agoMethotrexate belongs to a class of drugs known as antimetabolites and will be sold under the Elite Laboratories, Inc. label. IQVIA reported annual sales of $64.3 million for ...
Amphastar Receives FDA Approval for Albuterol Sulfate Inhalation Aerosol
Digital Journal· 2 days agoRANCHO CUCAMONGA, CA / ACCESSWIRE / May 22, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) today announced that the U.S. Food and Drug Administration ("FDA") has granted approval for the ...
AP News in Brief at 6:04 p.m. EDT
Idaho State Journal· 2 days agoNorway, Ireland and Spain said Wednesday they would recognize a Palestinian state, a historic but largely symbolic move that further deepens Israel’s isolation more than seven months into its ...
Cipla receives final USFDA nod for Lanreotide injection to treat tumours
Investing.com· 3 days agoCipla receives final USFDA nod for Lanreotide injection to treat tumours
Use of Wegovy and other weight-loss drugs soars among kids and young adults
The News-Times· 2 days agoAt 17, Israel McKenzie was so burdened by obesity that he stopped going to high school in person and...
Young people are increasingly using Wegovy and Oze | Newswise
Newswise· 3 days agoPublic interest in weight loss drugs like Wegovy and Ozempic is surging, but national data on dispensing patterns in the United States are surprisingly scarce. Now, a national study from Michigan ...
Elite Pharmaceuticals Receives FDA Approval for Generic Methotrexate
Morningstar· 5 days agoNORTHVALE, NJ / ACCESSWIRE / May 20, 2024 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, today announced that it received approval from the US Food and Drug
Use of Wegovy and other weight-loss drugs soars among kids and young adults
McComb Enterprise-Journal· 2 days agoIn 2023, the weight-loss drug Wegovy helped him shed 110 pounds in nine months, making him part of what new research shows is a sharp surge in the use of powerful medications to treat diabetes ...
